ArticleMolecular medicine (Cambridge, Mass.)2023

Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis.

Tingli Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.